Trials / Completed
CompletedNCT01390922
Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)
Special Drug Use Investigation for Botox® (Botulinum) Spasticity
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,038 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of this post-marketing surveillance study is to collect safety, efficacy and usage data on botulinum injection in subjects with upper or lower limb spasticity on the long-term use in clinical practice and to identify the factors affecting the safety or efficacy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum Toxin Type A | Botulinum Toxin Type A |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2011-07-11
- Last updated
- 2015-03-27
Source: ClinicalTrials.gov record NCT01390922. Inclusion in this directory is not an endorsement.